NO20004053D0 - Glucocorticoid-selective anti-inflammatory agents - Google Patents

Glucocorticoid-selective anti-inflammatory agents

Info

Publication number
NO20004053D0
NO20004053D0 NO20004053A NO20004053A NO20004053D0 NO 20004053 D0 NO20004053 D0 NO 20004053D0 NO 20004053 A NO20004053 A NO 20004053A NO 20004053 A NO20004053 A NO 20004053A NO 20004053 D0 NO20004053 D0 NO 20004053D0
Authority
NO
Norway
Prior art keywords
glucocorticoid
inflammatory agents
selective anti
mammal
compounds
Prior art date
Application number
NO20004053A
Other languages
Norwegian (no)
Other versions
NO20004053L (en
Inventor
Michael J Coughlan
Steven W Elmore
Michael E Kort
Philip R Kym
Jimmie L Moore
John K Pratt
Alan X Wang
James P Edwards
Todd Kevin Jones
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Publication of NO20004053D0 publication Critical patent/NO20004053D0/en
Publication of NO20004053L publication Critical patent/NO20004053L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds having Formula (I), are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of inhibiting immune or autoimmune diseases in a mammal.
NO20004053A 1998-02-13 2000-08-11 Glucocorticoid-selective anti-inflammatory agents NO20004053L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO20004053D0 true NO20004053D0 (en) 2000-08-11
NO20004053L NO20004053L (en) 2000-09-11

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004053A NO20004053L (en) 1998-02-13 2000-08-11 Glucocorticoid-selective anti-inflammatory agents

Country Status (20)

Country Link
EP (1) EP1053239B1 (en)
JP (1) JP2002503665A (en)
KR (1) KR20010040935A (en)
CN (1) CN1119348C (en)
AT (1) ATE230749T1 (en)
AU (1) AU766441B2 (en)
BG (1) BG64317B1 (en)
BR (1) BR9907788A (en)
CA (1) CA2320943A1 (en)
DE (1) DE69904804T2 (en)
DK (1) DK1053239T3 (en)
ES (1) ES2192035T3 (en)
HU (1) HUP0100460A3 (en)
IL (1) IL137508A0 (en)
NO (1) NO20004053L (en)
NZ (1) NZ506013A (en)
PL (1) PL193323B1 (en)
SK (1) SK284689B6 (en)
TR (1) TR200003094T2 (en)
WO (1) WO1999041256A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
CO5180649A1 (en) * 1999-09-01 2002-07-30 Abbott Lab ANTAGONISTS OF GLUCOCORTICOID RECEPTORS FOR THE TREATMENT OF DIABETES FOR THE TREATMENT OF DIABETES
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
ES2246292T3 (en) 2000-10-30 2006-02-16 Pfizer Products Inc. GLUCOCORTICOID RECEIVER MODULATORS.
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) * 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
WO2003059899A1 (en) 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
AU2003230700A1 (en) 2002-03-26 2003-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
PL373043A1 (en) 2002-03-26 2005-08-08 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003221706B2 (en) 2002-04-11 2008-02-28 Merck Sharp & Dohme Corp. 1H-Benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE60322713D1 (en) 2002-08-21 2008-09-18 Boehringer Ingelheim Pharma SUBSTITUTED DIHYDROCHINOLINS AS GLUCOCORTICOID MMIMETICS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS AND THEIR USE
EP1551845A1 (en) * 2002-10-11 2005-07-13 Ligand Pharmaceuticals, Inc. 5-CYCLOALKENYL 5 i H /i -CHROMENO 3,4-F QUINOLINE DERIV ATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
DE20301728U1 (en) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituted-7,9-difluoro-5H-chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulator compounds
AU2003258047A1 (en) 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO(3,4-f)QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
AU2003297471A1 (en) 2003-01-03 2004-08-10 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (en) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma GLUCOCORTICOID MIMETICS, METHODS OF PREPARATION PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME
EP1675839B1 (en) 2003-10-16 2007-07-11 Boehringer Ingelheim Pharmaceuticals Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7635711B2 (en) 2004-12-27 2009-12-22 Boehringer-Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1944290B1 (en) * 2005-09-14 2013-12-04 Santen Pharmaceutical Co., Ltd. Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
EP2443134A2 (en) 2009-06-16 2012-04-25 Schering Corporation NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
JP2013500962A (en) 2009-07-31 2013-01-10 カディラ ヘルスケア リミティド Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019458A2 (en) * 1994-12-22 1996-06-27 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
EP1053239B1 (en) 2003-01-08
BR9907788A (en) 2001-10-30
PL343018A1 (en) 2001-07-30
IL137508A0 (en) 2001-07-24
NZ506013A (en) 2003-03-28
HUP0100460A3 (en) 2003-03-28
DK1053239T3 (en) 2003-04-22
CA2320943A1 (en) 1999-09-19
NO20004053L (en) 2000-09-11
SK11972000A3 (en) 2001-08-06
WO1999041256A1 (en) 1999-08-19
SK284689B6 (en) 2005-09-08
BG104719A (en) 2001-05-31
AU2677399A (en) 1999-08-30
CN1296486A (en) 2001-05-23
TR200003094T2 (en) 2001-01-22
KR20010040935A (en) 2001-05-15
AU766441B2 (en) 2003-10-16
HUP0100460A2 (en) 2001-09-28
DE69904804T2 (en) 2003-11-06
EP1053239A1 (en) 2000-11-22
HK1033308A1 (en) 2001-08-24
CN1119348C (en) 2003-08-27
DE69904804D1 (en) 2003-02-13
ES2192035T3 (en) 2003-09-16
ATE230749T1 (en) 2003-01-15
PL193323B1 (en) 2007-02-28
JP2002503665A (en) 2002-02-05
BG64317B1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
DK1053239T3 (en) Gluccocorticoid-selective, anti-inflammatory agents
DK1053240T3 (en) Glucocorticoid-selective anti-inflammatory agents
BR0112160A (en) Glucocorticoid Selective Anti-Inflammatory Agents
BG105109A (en) Cell adhesion-inhibiting anti-inflammatory compounds
EP1034164A4 (en) ALANINE-BETA DERIVATIVES ACTING AS CELL ADHESION INHIBITORS
FI973087A7 (en) Cell adhesion inhibitors
BG105880A (en) Compounds useful as anti-inflammatory agents
BR9811099A (en) Urokinase inhibitors
DE69925508D1 (en) CELL ADHESION AND INFLAMMATORY IMMUNOSUPPRESSIVE COMPOUNDS
DK0869965T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
WO2000006137A3 (en) Glucocorticoid-selective anti-inflammatory agents
BG100248A (en) SQUALENSENTEZA INHIBITORS
IT1274022B (en) PHARMACOLOGICAL ACTIVITIES OF CUMARINA, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application